simufilam Search Results


simufilam  (MedChemExpress)
94
MedChemExpress simufilam
Simufilam, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/simufilam/product/MedChemExpress
Average 94 stars, based on 1 article reviews
simufilam - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
simufilam  (Cassava Sciences Inc)
90
Cassava Sciences Inc simufilam
Agents in Phase 3 Alzheimer's disease drug development (clinicaltrials.gov accessed January 1, 2024).
Simufilam, supplied by Cassava Sciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/simufilam/product/Cassava Sciences Inc
Average 90 stars, based on 1 article reviews
simufilam - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
simufilam pti-125  (Proteostasis Therapeutics)
90
Proteostasis Therapeutics simufilam pti-125
Agents in Phase 3 Alzheimer's disease drug development (clinicaltrials.gov accessed January 1, 2024).
Simufilam Pti 125, supplied by Proteostasis Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/simufilam pti-125/product/Proteostasis Therapeutics
Average 90 stars, based on 1 article reviews
simufilam pti-125 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
simufilam tablets  (Cassava Sciences Inc)
90
Cassava Sciences Inc simufilam tablets
Agents in Phase 3 Alzheimer's disease drug development (clinicaltrials.gov accessed January 1, 2024).
Simufilam Tablets, supplied by Cassava Sciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/simufilam tablets/product/Cassava Sciences Inc
Average 90 stars, based on 1 article reviews
simufilam tablets - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
simufilam  (Evonik)
90
Evonik simufilam
Agents in Phase 3 Alzheimer's disease drug development (clinicaltrials.gov accessed January 1, 2024).
Simufilam, supplied by Evonik, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/simufilam/product/Evonik
Average 90 stars, based on 1 article reviews
simufilam - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Agents in Phase 3 Alzheimer's disease drug development (clinicaltrials.gov accessed January 1, 2024).

Journal: Alzheimer's & Dementia : Translational Research & Clinical Interventions

Article Title: Alzheimer's disease drug development pipeline: 2024

doi: 10.1002/trc2.12465

Figure Lengend Snippet: Agents in Phase 3 Alzheimer's disease drug development (clinicaltrials.gov accessed January 1, 2024).

Article Snippet: Simufilam , Disease‐modifying small molecule , Synaptic plasticity/neuroprotection , Filamin A conformation stabilizer; disrupts the interaction of filamin A with the alpha 7 nicotinic acetylcholine receptor to reduce tau hyperphosphorylation and neurodegeneration; dependent on A‐beta's signaling via the alpha 7 pathway , NCT05352763 , Cassava Sciences, Inc. , May 2022 , Oct 2025.

Techniques: Clinical Proteomics, Inhibition, Activity Assay

Agents in Phase 2 Alzheimer's disease drug development (clinicaltrials.gov accessed January 1, 2024).

Journal: Alzheimer's & Dementia : Translational Research & Clinical Interventions

Article Title: Alzheimer's disease drug development pipeline: 2024

doi: 10.1002/trc2.12465

Figure Lengend Snippet: Agents in Phase 2 Alzheimer's disease drug development (clinicaltrials.gov accessed January 1, 2024).

Article Snippet: Simufilam , Disease‐modifying small molecule , Synaptic plasticity/neuroprotection , Filamin A conformation stabilizer; disrupts the interaction of filamin A with the alpha 7 nicotinic acetylcholine receptor to reduce tau hyperphosphorylation and neurodegeneration; dependent on A‐beta's signaling via the alpha 7 pathway , NCT05352763 , Cassava Sciences, Inc. , May 2022 , Oct 2025.

Techniques: Mutagenesis, Binding Assay, Activity Assay, Clinical Proteomics, Virus, Reverse Transcription, Plasmid Preparation, Expressing